Author

Jeroen Geldof

Getting the basics right: Prompt diagnosis and patient engagement
Getting the basics right: Prompt diagnosis and patient engagement

Jeroen Geldof

PROPHYLACTIC VERSUS ENDOSCOPY-DRIVEN TREATMENT OF CROHN’S POSTOPERATIVE RECURRENCE: COMPLETED RESULTS OF A RETROSPECTIVE, MULTICENTRIC EUROPEAN STUDY (PORCSE STUDY)
PROPHYLACTIC VERSUS ENDOSCOPY-DRIVEN TREATMENT OF CROHN’S POSTOPERATIVE RECURRENCE: COMPLETED RESULTS OF A RETROSPECTIVE, MULTICENTRIC EUROPEAN STUDY (PORCSE STUDY)

Jeroen Geldof  et al.

Panel discussion: How do you see UC?
Panel discussion: How do you see UC?

Jeroen Geldof  et al.

SAFETY OF VEDOLIZUMAB, USTEKINUMAB AND TNF INHIBITORS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE MONOCENTRIC COHORT STUDY
SAFETY OF VEDOLIZUMAB, USTEKINUMAB AND TNF INHIBITORS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE MONOCENTRIC COHORT STUDY

Jeroen Geldof  et al.

THE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND TNF INHIBITORS IN BIO-NAÏVE PATIENTS WITH IBD: RESULTS FROM A REAL-WORLD EXPERIENCE AT A BELGIAN TERTIARY CENTRE
THE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB AND TNF INHIBITORS IN BIO-NAÏVE PATIENTS WITH IBD: RESULTS FROM A REAL-WORLD EXPERIENCE AT A BELGIAN TERTIARY CENTRE

Jeroen Geldof  et al.

THE COMPARATIVE EFFECTIVENESS OF ANTI-TNF IN BIO-NAÏVE AND BIO-EXPERIENCED PATIENTS WITH IBD: RESULTS FROM A REAL-WORLD EXPERIENCE AT A BELGIAN TERTIARY CENTRE
THE COMPARATIVE EFFECTIVENESS OF ANTI-TNF IN BIO-NAÏVE AND BIO-EXPERIENCED PATIENTS WITH IBD: RESULTS FROM A REAL-WORLD EXPERIENCE AT A BELGIAN TERTIARY CENTRE

Jeroen Geldof  et al.

THE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB IN BIO-NAÏVE AND BIO-EXPERIENCED PATIENTS WITH IBD: RESULTS FROM A REAL-WORLD EXPERIENCE AT A BELGIAN TERTIARY CENTRE
THE COMPARATIVE EFFECTIVENESS OF VEDOLIZUMAB IN BIO-NAÏVE AND BIO-EXPERIENCED PATIENTS WITH IBD: RESULTS FROM A REAL-WORLD EXPERIENCE AT A BELGIAN TERTIARY CENTRE

Jeroen Geldof  et al.

SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY IBD PATIENTS: A REAL-LIFE MULTICENTRIC COHORT STUDY
SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY IBD PATIENTS: A REAL-LIFE MULTICENTRIC COHORT STUDY

Jeroen Geldof  et al.

Item 1 - 8 / 8
1